Cargando…

Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data

BACKGROUND: Methotrexate is the preferred initial disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA). However, clinically useful tools for individualized prediction of response to methotrexate treatment in patients with RA are lacking. We aimed to identify clinical predictors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duong, Stephanie Q., Crowson, Cynthia S., Athreya, Arjun, Atkinson, Elizabeth J., Davis, John M., Warrington, Kenneth J., Matteson, Eric L., Weinshilboum, Richard, Wang, Liewei, Myasoedova, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248180/ https://www.ncbi.nlm.nih.gov/pubmed/35778714 http://dx.doi.org/10.1186/s13075-022-02851-5

Ejemplares similares

Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging
por: Vassilaki, Maria, et al.
Publicado: (2022)

Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort
por: Davis, John M., et al.
Publicado: (2020)

Comprehensive assessment of multimorbidity burden in a population-based cohort of patients with rheumatoid arthritis
por: Crowson, Cynthia S, et al.
Publicado: (2022)

Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study
por: Peterson, Madeline N., et al.
Publicado: (2021)

Comparison of Biologic Discontinuation in Patients With Elderly‐Onset Versus Younger‐Onset Rheumatoid Arthritis
por: Richter, Michael D., et al.
Publicado: (2019)

Prevalence and Risk Factors of Gastrointestinal Disorders in Patients with Rheumatoid Arthritis: Results from a Population-Based Survey in Olmsted County, Minnesota
por: Myasoedova, Elena, et al.
Publicado: (2011)

Hyperuricemia and Incident Cardiovascular Disease and Noncardiac Vascular Events in Patients with Rheumatoid Arthritis
por: Kuo, Daniel, et al.
Publicado: (2014)

Increased Incidence of Atrial Fibrillation in Patients with Rheumatoid Arthritis
por: Bacani, A. Kirstin, et al.
Publicado: (2015)

Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis
por: Gupta, Vinod K., et al.
Publicado: (2021)

Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009
por: Olson, Timothy C, et al.
Publicado: (2011)

Risk of Malignant Neoplasm in Patients with Incident Rheumatoid Arthritis 1980–2007 in relation to a Comparator Cohort: A Population-Based Study
por: Raheel, Shafay, et al.
Publicado: (2016)

Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
por: Montes, Daniel, et al.
Publicado: (2023)

Determinants of Disability in Rheumatoid Arthritis: A Community-Based Cohort Study
por: Krause, Megan L., et al.
Publicado: (2015)

Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation
por: Challa, Divya N., et al.
Publicado: (2017)

Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis—A Cross‐Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve When Goals Are Discussed
por: O’Neill, Kelly D., et al.
Publicado: (2021)

Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?
por: Wing, Simon, et al.
Publicado: (2015)

A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis
por: Davis, John M, et al.
Publicado: (2012)

Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
por: Lima, Aurea, et al.
Publicado: (2015)

Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response
por: Yan, Huanhuan, et al.
Publicado: (2021)

Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity
por: Davis, John M, et al.
Publicado: (2013)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors
por: Challa, Divya N. V., et al.
Publicado: (2017)

Clinical and Laboratory Associations with Methotrexate Metabolism Gene Polymorphisms in Rheumatoid Arthritis
por: D’Cruz, Leon G., et al.
Publicado: (2020)

Exploring the Role of Antinuclear Antibody Positivity in the Diagnosis, Treatment, and Health Outcomes of Patients With Rheumatoid Arthritis
por: Paknikar, Sujaytha S., et al.
Publicado: (2021)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016)

Functional coding haplotypes and machine-learning feature elimination identifies predictors of Methotrexate Response in Rheumatoid Arthritis patients
por: Lim, Ashley J.W., et al.
Publicado: (2022)

Cardiovascular Risk in Psoriasis: A Population-Based Analysis with Assessment of the Framingham Risk Score
por: Myasoedova, Elena, et al.
Publicado: (2013)

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
por: Bulatović Ćalasan, Maja, et al.
Publicado: (2013)

Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
por: Ling, Stephanie F., et al.
Publicado: (2019)

Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis
por: Gosselt, Helen R., et al.
Publicado: (2021)

Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage
por: Gallo, G, et al.
Publicado: (2016)

The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis
por: Chara, Luis, et al.
Publicado: (2015)

Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice
por: Świerkot, Jerzy, et al.
Publicado: (2018)

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
por: Smolen, Josef S, et al.
Publicado: (2018)

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis
por: Gwinnutt, James M, et al.
Publicado: (2020)

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice
por: Karlsson Sundbaum, Johanna, et al.
Publicado: (2019)

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
por: Westhovens, R, et al.
Publicado: (2009)

A Clinical Audit of Cardiovascular Risk Factors and Disease in Patients with Rheumatoid Arthritis - SURF-RA
por: Semb, Anne Grete, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i84ic13fmg8v3edsa0lvilm0jd